-+ 0.00%
-+ 0.00%
-+ 0.00%

Firefly Neuroscience partners with Next Health on precision cognitive health platform

PUBT·07/28/2026 11:50:23
Listen to the news
Firefly Neuroscience partners with Next Health on precision cognitive health platform
  • Firefly Neuroscience entered a strategic partnership with Next Health to launch a precision cognitive health platform for longevity clinics.
  • Platform combines Firefly’s FDA 510(k)-cleared EEG/ERP brain biomarker technology with personalized physician-guided cognitive peptide protocols.
  • Partnership targets objective brain-function measurement to personalize, monitor, and optimize emerging cognitive therapies, replacing symptom-based assessments.
  • Launch follows an FDA advisory panel recommendation to ease compounding restrictions for six peptides, including Epitalon and Semax.
  • Companies plan standardized clinical protocols across Next Health’s expanding clinic network as adoption of quantitative neurodiagnostics accelerates.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Firefly Neuroscience Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607280750PRIMZONEFULLFEED9799106) on July 28, 2026, and is solely responsible for the information contained therein.